Quantitative detection of viral gene expression in populations of Epstein-Barr virus-infected cells in vivo.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Author(s): Hochberg DR;Hochberg DR; Thorley-Lawson DA
  • Source:
    Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2005; Vol. 292, pp. 39-56.
  • Publication Type:
    Journal Article
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Humana Press Country of Publication: United States NLM ID: 9214969 Publication Model: Print Cited Medium: Print ISSN: 1064-3745 (Print) Linking ISSN: 10643745 NLM ISO Abbreviation: Methods Mol Biol Subsets: MEDLINE
    • Publication Information:
      Publication: Totowa, NJ : Humana Press
      Original Publication: Clifton, N.J. : Humana Press,
    • Subject Terms:
      Epstein-Barr Virus Infections/*metabolism ; Gene Expression/*physiology ; Gene Expression Profiling/*methods ; Herpesvirus 4, Human/*genetics ; RNA/*analysis; Epstein-Barr Virus Infections/genetics ; Humans
    • Abstract:
      The method described in this chapter uses limiting dilution analysis in conjunction with RT-PCR to determine quantitatively what percentage of EBV-infected cells within a given population are expressing the viral genes EBNA-1 Q-K, EBNA-2, LMP-1, LMP-2, BZLF-1, and the EBERs. Because this technique involves limiting dilution analysis, it is possible to define which viral transcription programs are being used at the single-cell level. This assay takes 3-4 d to complete and involves the following steps: (1) sample preparation and isolation of the cell population of interest; (2) DNA-PCR limiting dilution analysis to determine the frequency of infected cells within the cell population; (3) RNA isolation; (4) cDNA synthesis; (5) PCR; (6) visualization of PCR products by Southern blotting; and (7) calculations. As an example, we have used PBMCs from the blood of an acute infectious mononucleosis patient. However, this technique can be applied to other cell populations, such as B cells, and other patient groups, such as healthy long-term virus carriers and immunosuppressed organ transplant recipients.
    • Accession Number:
      63231-63-0 (RNA)
    • Publication Date:
      Date Created: 20041028 Date Completed: 20050301 Latest Revision: 20190902
    • Publication Date:
      20240829
    • Accession Number:
      10.1385/1-59259-848-x:039
    • Accession Number:
      15507700